Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: A report from the Children's Oncology Group-Reference-Cited by-同舟云学术

Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: A report from the Children's Oncology Group

Published:2009-01 Issue:1 Volume:52 Page:44-50
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Park Julie R.,Villablanca Judith G.,London Wendy B.,Gerbing Robert B.,Haas-Kogan Daphne,Adkins E. Stanton,Attiyeh Edward F.,Maris John M.,Seeger Robert C.,Reynolds C. Patrick,Matthay Katherine K.

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference16 articles.

1. Successful treatment of stage 3 neuroblastoma based on prospective biologic staging: A Children's Cancer Group study;Matthay;J Clin Oncol,1998

2. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's cancer group;Matthay;N Engl J Med,1999

3. Histophatologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglineuroblastoma and an age-linked classification of neuroblastomas;Shimada;J Natl Cancer Inst,1984

4. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment;Brodeur;J Clin Oncol,1993

5. Chromosome 1p and 11q deletions and outcome in neuroblastoma;Attiyeh;N Engl J Med,2005

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and withoutMYCNAmplification: A Children's Oncology Group (COG) Report;Clinical Cancer Research;2023-02-07

2. Is FGFR4 Gly388Arg missense variant a suitable prognostic marker in neuroblastoma?;Journal of Cancer Research and Therapeutics;2023

3. Neuroblastoma;Epigenetic Cancer Therapy;2023

4. The impact of response to induction chemotherapy on the event-free and overall survival in patients with high-risk neuroblastoma: a systematic review and meta-analysis;Pediatric Hematology/Oncology and Immunopathology;2022-06-25

5. Expression of neuroblastoma‐related genes in bone marrow at end of high‐risk neuroblastoma therapy;Pediatric Blood & Cancer;2022-04-20